Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

C. Strina · SciRah

Researcher profile · Semantic Scholar

C. Strina

Share profile

C. Strina — researcher profile on SciRah

h-index: 13
Works: 53
Citations: 612

Most-cited papers

ADAM10 mediates trastuzumab resistance and is correlated with survival in HER2 positive breast cancer
K. Feldinger, D. Generali, Gabriela Kramer-Marek, M. Gijsen +14 more
2014OncoTarget85 citations Open access
Semantic Scholar
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial
V. Ferrari, F. Valcamonico, V. Amoroso, E. Simoncini +8 more
2005Cancer Chemotherapy and Pharmacology84 citations
Semantic Scholar
Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
G. Allevi, C. Strina, D. Andreis, V. Zanoni +14 more
2013British Journal of Cancer71 citations Open access
Semantic Scholar
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer
S. Nafi, D. Generali, Gabriela Kramer-Marek, M. Gijsen +10 more
2014OncoTarget69 citations Open access
Semantic Scholar
Combination of letrozole, metronomic cyclophosphamide and sorafenib is well-tolerated and shows activity in patients with primary breast cancer
L. Bazzola, C. Foroni, D. Andreis, V. Zanoni +19 more
2014British Journal of Cancer31 citations Open access
Semantic Scholar
Prospective neoadjuvant analysis of PET imaging and mechanisms of resistance to Trastuzumab shows role of HIF1 and autophagy
M. Koukourakis, A. Giatromanolaki, A. Bottini, M. Cappelletti +12 more
2014British Journal of Cancer20 citations Open access
Semantic Scholar
Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
A. Fabi, L. Carbognin, A. Botticelli, I. Paris +20 more
2023npj Breast Cancer19 citations Open access
Semantic Scholar
Clinical, Radiometabolic and Immunologic Effects of Olaparib in Locally Advanced Triple Negative Breast Cancer: The OLTRE Window of Opportunity Trial
F. Schettini, S. P. Corona, F. Giudici, C. Strina +23 more
2021Frontiers in Oncology18 citations Open access
Semantic Scholar
Faecal microbiota composition is related to response to CDK4/6-inhibitors in metastatic breast cancer: A prospective cross-sectional exploratory study.
F. Schettini, Alessandra Fontana, F. Gattazzo, C. Strina +7 more
2023European Journal of Cancer17 citations Open access
Semantic Scholar
Immune system and angiogenesis-related potential surrogate biomarkers of response to everolimus-based treatment in hormone receptor-positive breast cancer: an exploratory study
F. Schettini, Navid Sobhani, A. Ianza, T. Triulzi +14 more
2020Breast Cancer Research and Treatment15 citations Open access
Semantic Scholar
Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer.
D. Andreis, S. Bonardi, G. Allevi, S. Aguggini +16 more
2016Breast15 citations Open access
Semantic Scholar
Pure anti-tumor effect of zoledronic acid in naïve bone-only metastatic and locally advanced breast cancer: proof from the “biological window therapy”
C. Foroni, M. Milan, C. Strina, M. Cappelletti +18 more
2014Breast Cancer Research and Treatment14 citations
Semantic Scholar
ΔKi67 proliferation index as independent predictive and prognostic factor of outcome in luminal breast cancer: data from neoadjuvant letrozole-based treatment
A. Ianza, F. Giudici, C. Pinello, S. P. Corona +14 more
2020Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine13 citations Open access
Semantic Scholar
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: A literature-based meta-analysis of randomized trials.
S. P. Corona, G. Roviello, C. Strina, M. Milani +16 more
2019Breast13 citations Open access
Semantic Scholar
Hypoxia-related biological markers as predictors of epirubicin-based treatment responsiveness and resistance in locally advanced breast cancer
M. Milani, S. Venturini, S. Bonardi, G. Allevi +13 more
2017OncoTarget13 citations Open access
Semantic Scholar
Tumor Type Agnostic Therapy Carrying BRAF Mutation: Case Reports and Review of Literature
O. Bernocchi, Marianna Sirico, S. P. Corona, C. Strina +8 more
2021Pharmaceuticals12 citations Open access
Semantic Scholar
Bone Metastases from Primary Cardiac Sarcoma: Case Report
C. Strina, M. Zannoni, V. Parolin, G. Cetto +1 more
2009Tumori12 citations
Semantic Scholar
A Phase II study of olaparib in breast cancer patients: biological evaluation from a 'window of opportunity' trial.
G. Roviello, M. Milani, A. Gobbi, M. Dester +11 more
2016Future Oncology9 citations
Semantic Scholar
Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response.
D. Generali, A. Berruti, M. Cappelletti, L. Zanotti +14 more
2015Journal of the National Cancer Institute. Monographs9 citations Open access
Semantic Scholar
Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?
D. Generali, M. Ardine, C. Strina, M. Milani +10 more
2015Journal of the National Cancer Institute. Monographs9 citations Open access
Semantic Scholar
Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer
Marianna Sirico, O. Bernocchi, Navid Sobhani, F. Giudici +13 more
2020Cancers8 citations Open access
Semantic Scholar
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study
F. Schettini, S. Saracchini, A. Bassini, W. Marus +14 more
2024Breast6 citations Open access
Semantic Scholar
A Phase Ib Open-Label Study to Assess the Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-Negative Breast Cancers.
G. Roviello, M. Milani, A. Gobbi, M. Cappelletti +6 more
2016Clinical Breast Cancer6 citations Open access
Semantic Scholar
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry
L. Garrigós, C. Saura, C. Martinez-Vila, A. Zambelli +64 more
2021Therapeutic Advances in Medical Oncology5 citations Open access
Semantic Scholar
Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study
S. P. Corona, F. Giudici, G. Jerusalem, E. Ciruelos +10 more
2020OncoTarget5 citations Open access
Semantic Scholar
Could gonadotropin-releasing hormone analogs be helpful in the treatment of triple-negative breast cancer?
S. P. Corona, G. Roviello, C. Strina, M. Milani +4 more
2017Future Oncology5 citations
Semantic Scholar
Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the “MOZART” prospective observational study
F. Schettini, Marianna Sirico, M. Loddo, Gareth Williams +17 more
2024The Oncologist4 citations Open access
Semantic Scholar
Computational reactive–diffusive modeling for stratification and prognosis determination of patients with breast cancer receiving Olaparib
F. Schettini, M. D. De Bonis, C. Strina, M. Milani +14 more
2023Scientific Reports4 citations Open access
Semantic Scholar
352TiP Neoadjuvant chemo-immunotherapy plus/minus fasting-like approach in stage II-III triple-negative breast cancer patients: The phase II randomized BREAKFAST-2 trial
C. Vernieri, F. Ligorio, M. Dieci, M. Lambertini +16 more
2023Annals of Oncology4 citations Open access
Semantic Scholar
Benefit of the addition of hormone therapy to neoadjuvant anthracycline-based chemotherapy for breast cancer: comparison of predicted and observed pCR
D. Generali, S. P. Corona, L. Pusztai, R. Rouzier +5 more
2018Journal of Cancer Research and Clinical Oncology4 citations Open access
Semantic Scholar
Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer.
S. Nafi, D. Generali, Gabriela Kramer-Marek, M. Gijsen +10 more
2014OncoTarget4 citations
Semantic Scholar
PTPN9 regulates HER3 phosphorylation during trastuzumab treatment and loss of PTPN9 is a potential biomarker for trastuzumab resistance in HER2 positive breast cancer
Abul Azad, Maryam Arshad, D. Generali, K. Feldinger +12 more
2024Cancer Communications3 citations Open access
Semantic Scholar
Clinico-Immunological Effects of a Single-Agent CDK4/6 Inhibitor in Advanced HR+/HER2− Breast Cancer Based on a Window of Opportunity Study
A. D'Angelo, F. Giudici, R. Chapman, Jacob Darlow +7 more
2022Current Issues in Molecular Biology3 citations Open access
Semantic Scholar
Efficacy of extended aromatase inhibitors for hormone-receptor-positive breast cancer: a literature based meta-analysis of randomized trials.
G. Roviello, O. Pagani, F. Meani, C. Strina +8 more
2017Annals of Oncology2 citations Open access
Semantic Scholar
Real-world effectiveness of CDK4/6 inhibitors in older patients with HR+/HER2- advanced breast cancer: a sub-analysis of the multicenter, PALMARES-2 study
F. Ligorio, L. Provenzano, G. Fotia, M. Dieci +74 more
2026Breast1 citations Open access
Semantic Scholar
Comparative efficacy between real-world and randomized studies of palbociclib+endocrine therapy in HR-positive/HER2-negative metastatic breast cancer: systematic review and meta-analysis
F. Schettini, S. Nucera, G. Di Grazia, Fabiola Giudici +17 more
2025JNCI Cancer Spectrum1 citations Open access
Semantic Scholar
A Mixed Probiotic/Prebiotic Intervention (MBR 01) for the Management of Diarrhea During Abemaciclib Treatment of Early Breast Cancer: A Single Center Prospective Case Control Pilot Study
D. Generali, A. Membrino, A. Fontana, F. Gattazzo +7 more
2026medRxiv0 citations
Semantic Scholar
A mixed prebiotic/probiotic intervention (MBR-01) for the management of diarrhea during abemaciclib treatment of early breast cancer in postmenopausal patients: A single-center prospective case–control pilot study
D. Generali, Alexandro Membrino, A. Fontana, F. Gattazzo +7 more
2026Breast0 citations Open access
Semantic Scholar
Real-World Patient-Reported Outcome Comparing Antibody-Drug Conjugates and Conventional Chemotherapy in Metastatic Breast Cancer.
Manuela Milani, Francesco Riccetelli, C. Strina, Marzia Alberio +7 more
2026The Oncologist0 citations Open access
Semantic Scholar
DPYD-Guided Dosing of Metronomic Capecitabine Plus Vinorelbine in Metastatic Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: A Real-World Retrospective Study
F. Schettini, Alexandro Membrino, G. Di Grazia, A. Caltavituro +12 more
2026JCO Precision Oncology0 citations Open access
Semantic Scholar
Clinical and economic impact of community-based cancer care: Results from the S.M.A.R.T. Care Project in metastatic breast cancer patients.
Manuela Milani, C. Strina, Marzia Alberio, V. Cervoni +7 more
2026Tumori0 citations
Semantic Scholar
Abstract P1-10-14: Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib+aromatase inhibitors (P+AI) in hormone receptor-positive(HR+)/HER2-negative(-) metastatic breast cancer (mBC)
D. Generali, S. Nucera, F. Schettini, Fabiola Giudici +16 more
2025Clinical Cancer Research0 citations
Semantic Scholar
357P Bridging the gap between real-world studies (RWSs) and randomized controlled trials (RCTs) of 1st-line palbociclib+aromatase inhibitors (P+AI) in hormone receptor-positive (HR+)/HER2-negative(-) metastatic breast cancer (mBC)
S. Nucera, F. Schettini, F. Giudici, C. Strina +16 more
2024Annals of Oncology0 citations
Semantic Scholar
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
A. Fabi, L. Carbognin, A. Botticelli, I. Paris +20 more
2024npj Breast Cancer0 citations Open access
Semantic Scholar
Assessing the long-term prognostic ability of the 70 gene expression signature MammaPrint in an Italian single-center prospective cohort study of early-stage intermediate-risk breast cancer patients
D. Generali, Andrea Rocca, C. Strina, Manuela Milani +15 more
2024Heliyon0 citations Open access
Semantic Scholar
Author Correction: Real-world ANASTASE study of atezolizumab+nab-paclitaxel as first-line treatment of PD-L1-positive metastatic triple-negative breast cancer
A. Fabi, L. Carbognin, A. Botticelli, I. Paris +20 more
2023npj Breast Cancer0 citations Open access
Semantic Scholar
P157 MammaPrint 8-year follow up results in patients with early breast cancer from a single-center Italian cohort study
E. Fiorino, F. Giudici, S. Aguggini, C. Strina +11 more
2023Breast0 citations Open access
Semantic Scholar
Addendum: Impact of BMI on the outcome of metastatic breast cancer patients treated with everolimus: a retrospective exploratory analysis of the BALLET study
S. P. Corona, F. Giudici, G. Jerusalem, E. Ciruelos +10 more
2022OncoTarget0 citations Open access
Semantic Scholar
Safety and activity of nonpegylated liposomal doxorubicin (nPLD) combined with oral metronomic cyclophosphamide (mC) as preoperative treatment for locally advanced breast cancer (BC) patients (pts).
D. Andreis, D. Generali, C. Foroni, L. Bazzola +10 more
20170 citations
Semantic Scholar
Abstract P6-05-08: Nuclear HER3 localisation plays a role in trastuzumab resistance in HER2-positive breast cancer
K. Hashimoto, I. Roxanis, D. Generali, D. Andreis +4 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Generali×27
Invite
D. Generali — researcher profile on SciRah
M. Milani×27
Invite
M. Milani — researcher profile on SciRah
M. Cappelletti×22
Invite
M. Cappelletti — researcher profile on SciRah
S. Aguggini×14
Invite
S. Aguggini — researcher profile on SciRah

×14

Invite

V. Cervoni — researcher profile on SciRah

S. P. Corona×11

Invite

S. P. Corona — researcher profile on SciRah

Invite

D. Andreis — researcher profile on SciRah

Invite

A. Bottini — researcher profile on SciRah

Marianna Sirico×10

Invite

Marianna Sirico — researcher profile on SciRah

N. Ziglioli×10

Invite

N. Ziglioli — researcher profile on SciRah

Invite

G. Allevi — researcher profile on SciRah

Invite

A. Harris — researcher profile on SciRah